Table 3.
HR OS (95% CI) | HR CSS (95% CI) | |||
---|---|---|---|---|
Age | 1.04 (1.04–1.05) | p<0.001 | 1.03 (1.02–1.04) | p<0.001 |
Sex | ||||
- Male | N/A | Reference | ||
- Female | 1.05 (0.87–1.26) | p=0.6 | ||
Tumor size | 1.003 (1.002–1.005) | p<0.001 | 1.004 (1.001–1.01) | p=0.003 |
Tumor Grade | ||||
- Grade 1 | Reference | Reference | ||
- Grade 2 | 1.43 (0.93–2.20) | p=0.1 | 2.53 (0.91–6.07) | p=0.054 |
- Grade 3 | 2.01 (1.33–3.03) | p=0.001 | 5.12 (2.03–12.49) | p<0.001 |
- Grade 4 | 2.26 (1.51–3.40) | p<0.001 | 5.74 (2.32–14.18) | p<0.001 |
- Unknown | 2.01 (1.22–3.32) | p=0.006 | 5.13 (2.11–15.46) | p=0.001 |
pT stage | ||||
- T1 | Reference | Reference | ||
- T2 | 1.44 (1.17–1.77) | p=0.001 | 1.64 (1.17–2.24) | p=0.003 |
- T3 | 2.20 (1.85–2.63) | p<0.001 | 3.08 (2.37–4.09) | p<0.001 |
- T4 | 4.13 (3.19–5.34) | p<0.001 | 6.16 (4.37–9.21) | p<0.001 |
- Unknown | 3.88 (0.95–15.87) | p=0.06 | 7.82 (1.09–60.34) | p=0.04 |
pN stage | ||||
- N0 | Reference | Reference | ||
- N1 | 2.01 (1.48–2.72) | p<0.001 | 2.33 (1.50–3.28) | p<0.001 |
- N2/3 | 1.94 (1.34–2.81) | p<0.001 | 1.83 (1.04–3.15) | p=0.01 |
- Nx | 1.12 (0.91–1.39) | p=0.3 | 0.97 (0.78–1.42) | p=0.8 |
pM stage | ||||
- M0 | Reference | Reference | ||
- M1 | 3.20 (2.42–4.23) | p<0.001 | 3.64 (2.59–5.12) | p<0.001 |
- Mx | 1.90 (1.16–3.13) | p=0.01 | 2.53 (1.39–4.61) | p=0.002 |
Tumor location | ||||
- Renal Pelvis | Reference | Reference | ||
- Ureter | 1.18 (1.03–1.35) | p=0.02 | 1.29 (1.07–1.56) | p=0.008 |
Number of Nodes Removed | 0.99 (0.97–1.02) | p=0.5 | 0.94 (0.91–0.98) | p=0.003 |